Your browser doesn't support javascript.
loading
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark
Kamille Fogh; Alexandra RR Eriksen; Rasmus B Hasselbalch; Emilie Sofie Kristensen; Henning Bundgaard; Susanne D Nielsen; Charlotte S Joergensen; Bibi FSS Scharff; Christian Erikstrup; Susanne G Saekmose; Dorte K Holm; Bitten Aagaard; Jakob B Norsk; Pernill B Nielsen; Jonas H Kristensen; Lars Oestergaard; Svend Ellermann-Eriksen; Berit Andersen; Henrik Nielsen; Isik S Johansen; Lothar Wiese; Lone Simonsen; Thea R Fischer; Fredrik Folke; Freddy Lippert; Sisse R Ostrowski; Steen Ethelberg; Anders Koch; Anne-Marie Vangsted; Tyra Grove Krause; Anders Formsgaard; Claus Nielsen; Henrik Ullum; Robert Skov; Kasper Iversen.
Afiliação
  • Kamille Fogh; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
  • Alexandra RR Eriksen; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
  • Rasmus B Hasselbalch; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
  • Emilie Sofie Kristensen; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
  • Henning Bundgaard; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark
  • Susanne D Nielsen; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark
  • Charlotte S Joergensen; Statens Serum Institut, Copenhagen Denmark
  • Bibi FSS Scharff; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Denmark
  • Christian Erikstrup; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark
  • Susanne G Saekmose; Department of Clinical Immunology, Zealand University Hospital, Koege, Denmark
  • Dorte K Holm; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark
  • Bitten Aagaard; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark
  • Jakob B Norsk; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
  • Pernill B Nielsen; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
  • Jonas H Kristensen; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
  • Lars Oestergaard; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
  • Svend Ellermann-Eriksen; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark
  • Berit Andersen; University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark
  • Henrik Nielsen; Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark
  • Isik S Johansen; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark
  • Lothar Wiese; Department of Infectious Diseases, Zealand University Hospital, Roskilde, Denmark
  • Lone Simonsen; Department of Science and Environment, University of Roskilde, Denmark
  • Thea R Fischer; Department of Clinical Research, North Zealand Hospital, Hilleroed, Denmark
  • Fredrik Folke; Copenhagen Emergency Medical Services, Copenhagen, Denmark
  • Freddy Lippert; Copenhagen Emergency Medical Services, Copenhagen, Denmark
  • Sisse R Ostrowski; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Denmark
  • Steen Ethelberg; Statens Serum Institut, Copenhagen Denmark
  • Anders Koch; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark and Statens Serum Institut, Copenhagen Denmark
  • Anne-Marie Vangsted; Statens Serum Institut, Copenhagen Denmark
  • Tyra Grove Krause; Statens Serum Institut, Copenhagen Denmark
  • Anders Formsgaard; Statens Serum Institut, Copenhagen Denmark
  • Claus Nielsen; Statens Serum Institut, Copenhagen Denmark
  • Henrik Ullum; Statens Serum Institut, Copenhagen Denmark
  • Robert Skov; Statens Serum Institut, Copenhagen Denmark
  • Kasper Iversen; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark and Department of Emergency Medicine, Copenhagen University Hospital, Her
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21256725
ABSTRACT
BackgroundCOVID-19 is suggested to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. MethodsAs part of "Testing Denmark", a nationwide sero-epidemiological surveillance survey, we conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas in Denmark. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning previous testing (viral throat- and nasopharyngeal swab or antibody test), test results for COVID-19, demographics, household characteristics, employment, risk factors for SARS-CoV-2 infection and history of symptoms associated with COVID-19. Data on seroprevalence from Danish blood donors in same period using a total Ig ELISA assay were used as a proxy for the general Danish population. FindingsOf the 13,279 included participants, 2,296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78-3.16, p>0.001). Seropositivity was higher among males than females (RR 1.1, 95% CI 1.05-1.22%, p=0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00-1.06, p=0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among members of the same households (OR 5.0, 95% CI 4.1-6.2 p<0,001). Adjusted for age, gender and region living at least 4 people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.1-1.6, p=0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1-1.5, p=0.007). Only 1.6% of participants reported not following any of the national COVID-19 recommendations. Anosmia (RR 3.2 95% CI 2.8-3.7, p<0.001) and ageusia (RR 3.3, 95% CI 2.9-3.8, p<0.001) were strongest associated with seropositivity. InterpretationDanish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased with age. Living in multiple generations or more than four persons in a household was an independent risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas.
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...